Literature DB >> 17560790

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter.

Amy B Manning-Boğ1, W Michael Caudle, Xiomara A Perez, Stephen H Reaney, Ronald Paletzki, Martha Z Isla, Vivian P Chou, Alison L McCormack, Gary W Miller, J William Langston, Charles R Gerfen, Donato A Dimonte.   

Abstract

Mutations in the gene for DJ-1 have been associated with early-onset autosomal recessive parkinsonism. Previous studies of null DJ-1 mice have shown alterations in striatal dopamine (DA) transmission with no DAergic cell loss. Here we characterize a new line of DJ-1-deficient mice. A subtle locomotor deficit was present in the absence of a change in striatal DA levels. However, increased [(3)H]-DA synaptosomal uptake and [(125)I]-RTI-121 binding were measured in null DJ-1 vs. wild-type mice. Western analyses of synaptosomes revealed significantly higher dopamine transporter (DAT) levels in pre-synaptic membrane fractions. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) exposure exacerbated striatal DA depletion in null DJ-1 mice with no difference in DAergic nigral cell loss. Furthermore, increased 1-methyl-4-phenylpyridinium (MPP(+)) synaptosomal uptake and enhanced MPP(+) accumulation were measured in DJ-1-deficient vs. control striatum. Thus, under null DJ-1 conditions, DAT changes likely contribute to altered DA neurotransmission and enhanced sensitivity to toxins that utilize DAT for nigrostriatal entry.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560790     DOI: 10.1016/j.nbd.2007.03.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  35 in total

1.  Keap1-Nrf2 activation in the presence and absence of DJ-1.

Authors:  Li Gan; Delinda A Johnson; Jeffrey A Johnson
Journal:  Eur J Neurosci       Date:  2010-03-03       Impact factor: 3.386

Review 2.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

Review 3.  Value of genetic models in understanding the cause and mechanisms of Parkinson's disease.

Authors:  Darren J Moore; Ted M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

Review 4.  DJ-1, PINK1, and their effects on mitochondrial pathways.

Authors:  Mark R Cookson
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

5.  Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.

Authors:  Vivian P Chou; Novie Ko; Theodore R Holman; Amy B Manning-Boğ
Journal:  J Vis Exp       Date:  2014-01-07       Impact factor: 1.355

Review 6.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

7.  DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.

Authors:  Chenere P Ramsey; Elpida Tsika; Harry Ischiropoulos; Benoit I Giasson
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

Review 8.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.

Authors:  David N Hauser; Teresa G Hastings
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

9.  Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis.

Authors:  Thomas S Guillot; Seneshaw A Asress; Jason R Richardson; Jonathan D Glass; Gary W Miller
Journal:  J Mot Behav       Date:  2008-11       Impact factor: 1.328

10.  Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Authors:  V P Chou; T R Holman; A B Manning-Bog
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.